Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2017 21:08 ET | Source: Cutting Edge Information

Global Pharma Companies Begin Conducting Comparative Effectiveness Research During Phase 3 of Product Development

RESEARCH TRIANGLE PARK, NC--(Marketwired - June 26, 2017) - Research from global market access teams found that pharmaceutical and medical device companies often wait until Phase 3 or later to...
July 21, 2016 08:17 ET | Source: Cutting Edge Information

Global Pharmaceutical Comparative Effectiveness Research Teams Increasing Budgets

RESEARCH TRIANGLE PARK, NC--(Marketwired - July 21, 2016) - Pharmaceutical companies' comparative effectiveness (CER) managers indicate upward trends in spending from an average $5 million budget,...
July 19, 2016 10:30 ET | Source: Industry Standard Research

Spend on HEOR Studies Expected to Grow at 9.7% Through 2020

CARY, NC--(Marketwired - July 19, 2016) - Industry Standard Research has released a new report, "Late Phase Study Trends and Market Outlook (2016-2020)," containing findings focused on current...
August 09, 2011 11:53 ET | Source: Cutting Edge Information

Drug Companies Spend an Average $13,000 per Patient on Comparative Effectiveness Research in Phase IV

RESEARCH TRIANGLE PARK, NC--(Marketwire - Aug 9, 2011) - The cost of running a comparative effectiveness trial is $13,087 per patient during Phase IV, according to a study by Cutting Edge...
October 20, 2009 09:15 ET | Source: Cutting Edge Information

Cutting Edge Information Analyzes How Drug Makers Embrace Comparative Effectiveness Research (CER)

RESEARCH TRIANGLE PARK, NC--(Marketwire - October 20, 2009) - A higher percentage of companies are using Comparative Effectiveness Research to help with pricing and reimbursement decisions, according...